The facial weakness characteristically involves the periorbital and perioral muscles, often asymmetrically, and is best demonstrated on attempting to puff out the cheeks or whistle. Periorbital weakness is recognised by weakness of eye closure, which if minimal, shows as inability to bury the eyelashes. 4 Despite earlier onset facial weakness, symptomatic onset is usually in teenage with shoulder girdle weakness, which is often initially unilateral, predominantly right sided, and may correlate with handedness.'7 Periscapular wasting and weakness resulting in scapular winging and inability to abduct the arm above the horizontal may be evident. Wasting and weakness of upper arm muscles often develops; distal progression leads to eventual weakness of wrist and finger extensors. ' While for some subjects muscle weakness remains restricted to a facioscapulohumeral distribution, in many others truncal, pelvic girdle, and lower limb muscles are also involved. The anterior tibial and peroneal muscles are often affected before more proximal ones, leading to the typical 'steppage' gait of this 'facioscapuloperoneal' presentation. Alternatively, lower limb weakness may develop in a descending order involving proximal before distal muscles. These two alternative presentations have previously been interpreted by some authors8 as indicative of genetic heterogeneity; others have found both presentations in single kindreds. 6 Truncal weakness may produce marked lumbar lordosis. Progression of weakness in those affected severely leads to proximal and distal weakness in both upper and lower limbs with requirement for a wheelchair.' The extraocular and bulbar musculature are spared specifically. 6 In seeking genetic counselling family members are concerned about the following: (1) risk of disability in their offspring, (2) own risk of disability, (3) appropriateness of exercise or other treatments, (4) prevalence of the disorder, (5) possibilities for predictive and prenatal testing.
clinical, electromyographic, histopathological, or, now, molecular genetic criteria. Recessive inheritance in facioscapulohumeral syndrome has been proposed for some families, especially with infantile onset.910 In many of these families minor signs of muscle weakness have been noted in one parent or in other members from previous generations.9-1" In other cases the presence of ptosis, which is not a feature of FSHD, suggests that an alternative diagnosis should be sought. '2 Muscle histology in FSHD often shows a relatively normal appearance, or shows some increase in fibre size variation, occasional internalisation of nuclei, and inflammatory response indicative of a myopathy. Small 
Results

INHERITANCE
Over 500 subjects from 41 families with FSHD were studied; 168 subjects were affected, 22 subjects over the age of 15 were scored as equivocal and excluded from further analysis, and approximately 330 appeared to be unaffected. Dominant inheritance could be proven in 28 families; in 17 of these at least four affected subjects were examined. There was no good evidence for recessive inheritance in the remaining families. In particular, there was no parental consanguinity in six isolated cases for whom both parents were unaffected on examination, nor in a further three cases where parental examination was not possible. Although the six isolated cases on average were younger and less severely affected than 28 other probands with FSHD from families with proven dominant inheritance ( 28 There were 56 cases ascertained from Wales (population 2-8 million), suggesting a minimum prevalence of 2-0/100 000. Within Cardiff (population 0-28 million) there were 12 cases (local prevalence 4-3/ 100 000) and from the rest of Glamorgan (population 1-01 million) there were 22 cases (prevalence 2-2/100 000). A further 15 young children resident in Wales were at close to 50% risk, suggesting a minimum birth incidence of 1/44 000.
RISK OF DISABILITY
Genetic counselling in FSHD requires reliable data for age dependent penetrance. Estimates of penetrance were obtained from this study, as discussed in 
GENETIC LINKAGE
The close linkage of D4S139 to FSHD now makes possible presymptomatic prediction and prenatal diagnosis in FSHD. By further analysis of these and other families it is hoped that the role of serum creatine kinase and retinal fluorescein angiography in presymptomatic testing, the reliability of the empirical method of scoring for affected status, and the possibility that other forms of muscular dystrophy could be caused by mutations at the FSHD locus can be assessed. The prospect of identifying the FSHD gene product from pursuit of physical methods for isolation and characterisation of the FSHD gene now provides a target for further research.
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